Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma

2 Feb 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways
Share to RNA regulation and disease

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30721788
DOI: 10.1016/j.ejca.2018.12.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanomaPMID 30721788Read ↗

Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities.Semantic proximity Read ↗

Triple therapy for BRAFV600-mutated melanoma.Semantic proximity Read ↗

Circumventing Melanoma Chemoresistance by Targeting DNA RepairSemantic proximity Read ↗

A novel combination treatment against melanoma with NRAS mutation and therapy resistance.Semantic proximity Read ↗

Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition.Semantic proximity Read ↗

Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas.Semantic proximity Read ↗

Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?Semantic proximity Read ↗

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.Semantic proximity Read ↗

BRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma.Semantic proximity Read ↗

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.Semantic proximity Read ↗

The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation studySemantic proximity Read ↗

Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.